Кодекс долголетия. Что заставляет нас стареть, зачем это нужно и как «обмануть» эволюцию: пошаговое руководство - читать онлайн книгу. Автор: Крис Вербург cтр.№ 90

читать книги онлайн бесплатно
 
 

Онлайн книга - Кодекс долголетия. Что заставляет нас стареть, зачем это нужно и как «обмануть» эволюцию: пошаговое руководство | Автор книги - Крис Вербург

Cтраница 90
читать онлайн книги бесплатно

105 L. M. L. de Lau et al., “Serum cholesterol levels and the risk of Parkinson’s disease.” American Journal of Epidemiology 164, no. 10 (November 2006): 998–1002.

106 L. Dupuis et al., “Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.” Neurology 70, no. 13 (March 2008): 1004–9.

107 X. Huang et al., “Low LDL cholesterol and increased risk of Parkinson’s disease: prospective results from Honolulu-Asia Aging Study.” Movement Disorders: Official Journal of the Movement Disorder Society 23, no. 7 (May 2008): 1013–18.

108 D. S. Ng et al., “HDL – is it too big to fail?” Nature Reviews Endocrinology 9, no. 5 (May 2013): 308–12.

109 N. Barzilai et al., “Unique lipoprotein phenotype and genotype associated with exceptional longevity.” JAMA 290, no. 15 (October 2003): 2030–40.

110 P. W. Siri-Tarino et al., “Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease.” American Journal of Clinical Nutrition 91, no. 3 (March 2010): 535–46.

111 M. U. Jakobsen et al., “Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies.” American Journal of Clinical Nutrition 89, no. 5 (May 2009): 1425–32.

112 R. P. Mensink et al., “Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials.” American Journal of Clinical Nutrition 77, no. 5 (May 2003): 1146–55.

113 J. E. Hokanson et al., “Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.” Journal of Cardiovascular Risk 3, no. 2 (April 1996): 213–19.

114 M. U. Jakobsen et al., “Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index.” American Journal of Clinical Nutrition 91, no. 6 (June 2010): 1764–68.

115 E. E. Canfora et al., “Short-chain fatty acids in control of body weight and insulin sensitivity.” Nature Reviews Endocrinology 11, no. 10 (August 2015): 577–91.

116 A. Andoh, “Physiological role of gut microbiota for maintaining human health.” Digestion 93, no. 3 (February 2016): 176–81.

117 A. Menotti et al., “Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group.” European Journal of Epidemiology 15, no. 6 (July 1999): 507–15.

118 C. B. Ebbeling et al., “Effects of dietary composition on energy expenditure during weight-loss maintenance.” JAMA 307, no. 24 (June 2012): 2627–34.

119 R. Estruch et al., “Primary prevention of cardiovascular disease with a Mediterranean diet.” New England Journal of Medicine 368, no. 14 (April 2013): 1279–90.

120 D. C. Wallace, “A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.” Annual Review of Genetics 39 (January 2005): 359–407.

121 B. Bernardes de Jesus et al., “Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer.” EMBO Molecular Medicine 4, no. 8 (August 2012): 691–704.

122 G. Atzmon et al., “Evolution in health and medicine Sackler colloquium: genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians.” Proceedings of the National Academy of Sciences of the United States of America 107 Suppl (January 2010): 1710–17.

123 M. Crous-Bou et al., “Mediterranean diet and telomere length in Nurses’ Health Study: population based cohort study.” BMJ (Clinical Research Ed.) 349 (January 2014): g6674.

124 P. Sjogren et al., “Stand up for health – avoiding sedentary behaviour might lengthen your telomeres: secondary outcomes from a physical activity RCT in older people.” British Journal of Sports Medicine 48, no. 19 (September 2014): 1407–9.

125 D. Ornish et al., “Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.” Lancet Oncology 14, no. 11 (October 2013): 1112–20.

126 C. W. Leung et al., “Soda and cell aging: associations between sugar-sweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys.” American Journal of Public Health 104, no. 12 (December 2014): 2425–31.

127 H. Holstege et al., “Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis.” Genome Research 24, no. 5 (April 2014): 733–42.

128 G. Bjelakovic et al., “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.” JAMA 297, no. 8 (February 2007): 842–57.

129 H. Macpherson et al., “Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials.” American Journal of Clinical Nutrition 97, no. 2 (March 2013): 437–44.

130 H. D. Sesso et al., “Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial.” JAMA 308, no. 17 (November 2012): 1751–60.

131 D. H. Baker, “Cupric oxide should not be used as a copper supplement for either animals or humans.” Journal of Nutrition 129, no. 12 (December 1999): 2278–79.

132 G. S. Omenn, “Chemoprevention of lung cancer: the rise and demise of betacarotene.” Annual Review of Public Health 19 (January 1998): 73–99.

133 B. K. Dunn et al., “A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).” Nutrition and Cancer 62, no. 7 (January 2010): 896–918.

134 L. C. Clark et al., “Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.” JAMA 276, no. 24 (December 1996): 1957–63.

135 A. Vogiatzoglou et al., “Vitamin B12 status and rate of brain volume loss in community-dwelling elderly.” Neurology 71, no. 11 (September 2008): 826–32.

136 G. Douaud et al., “Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment.” Proceedings of the National Academy of Sciences of the United States of America 110, no. 23 (June 2013): 9523–28.

137 N. L. van der Zwaluw et al., “Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.” Neurology 83, no. 23 (December 2014): 2158–66.

Вернуться к просмотру книги Перейти к Оглавлению Перейти к Примечанию